We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$745M
AUM Growth
+$100M
Cap. Flow
+$33.5M
Cap. Flow %
4.49%
Top 10 Hldgs %
32.1%
Holding
165
New
13
Increased
37
Reduced
77
Closed
11

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$4.4M
2
TDC icon
Teradata
TDC
+$3.37M
3
ALB icon
Albemarle
ALB
+$3.15M
4
LNN icon
Lindsay Corp
LNN
+$2.9M
5
CTVA icon
Corteva
CTVA
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.6%
2 Technology 23.47%
3 Industrials 19.04%
4 Utilities 16.65%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$82.9B
$36.4M 4.88%
403,364
-18,075
-4% -$1.56M
GLW icon
2
Corning
GLW
$126B
$26.9M 3.61%
619,278
-16,049
-3% -$617K
BMY icon
3
Bristol-Myers Squibb
BMY
$127B
$25M 3.35%
396,121
-6,200
-2% -$386K
INTC icon
4
Intel
INTC
$466B
$24.4M 3.28%
381,716
-5,900
-2% -$352K
PFE icon
5
Pfizer
PFE
$140B
$23.5M 3.15%
648,727
+41,416
+7% +$1.47M
T icon
6
AT&T
T
$165B
$21.8M 2.92%
952,540
+105,921
+13% +$2.34M
IBM icon
7
IBM
IBM
$202B
$20.9M 2.8%
164,101
+40,838
+33% +$4.89M
CSCO icon
8
Cisco
CSCO
$450B
$20.8M 2.79%
402,767
+94,300
+31% +$4.43M
XOM icon
9
ExxonMobil
XOM
$651B
$20.7M 2.77%
370,437
-7,555
-2% -$396K
GSK icon
10
GSK
GSK
$103B
$18.9M 2.53%
422,538
+94,765
+29% +$4.3M
MDU icon
11
MDU Resources
MDU
$4.44B
$18.8M 2.52%
1,565,665
-48,390
-3% -$527K
OGE icon
12
OGE Energy
OGE
$10.3B
$18.8M 2.52%
579,946
+31,733
+6% +$1M
AGX icon
13
Argan
AGX
$7.98B
$18.5M 2.49%
347,633
+38,067
+12% +$1.83M
XRAY icon
14
Dentsply Sirona
XRAY
$2.59B
$16.8M 2.26%
263,458
-5,050
-2% -$293K
FLS icon
15
Flowserve
FLS
$9.25B
$15.4M 2.07%
397,854
+11,723
+3% +$450K
BCE icon
16
BCE
BCE
$19.9B
$15.3M 2.05%
338,748
-3,320
-1% -$146K
NVS icon
17
Novartis
NVS
$295B
$15.2M 2.04%
177,464
+7,031
+4% +$631K
JNJ icon
18
Johnson & Johnson
JNJ
$635B
$14.8M 1.98%
89,999
-1,030
-1% -$167K
LGTY
19
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$14.6M 1.95%
703,078
-17,975
-2% -$360K
MMM icon
20
3M
MMM
$89B
$14.4M 1.93%
89,518
-2,572
-3% -$385K
VZ icon
21
Verizon
VZ
$194B
$14.3M 1.91%
245,388
+181,932
+287% +$10.3M
HE icon
22
Hawaiian Electric Industries
HE
$2.33B
$14.2M 1.91%
319,790
+125,590
+65% +$4.6M
ELAN icon
23
Elanco Animal Health
ELAN
$12.4B
$12.4M 1.66%
420,450
+149,350
+55% +$4.59M
D icon
24
Dominion Energy
D
$62.5B
$11.6M 1.55%
152,594
+24,150
+19% +$1.75M
LNN icon
25
Lindsay Corp
LNN
$1.16B
$11.2M 1.5%
67,125
-18,666
-22% -$2.9M

Similar funds

John G. Ullman & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, John G. Ullman & Associates held 165 positions worth $745M, up 16% from $645M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates deployed $33.5M of net new capital in Q1 2021, opening 13 new positions and adding to 37 existing holdings. Its largest new stake was American Tower: 11,570 shares worth $2.77M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Abbott, an estimated $4.4M trimmed.

  • John G. Ullman & Associates's largest Q1 2021 buy was American Tower: 11,570 shares worth $2.77M.
  • John G. Ullman & Associates added most to Verizon in Q1 2021, an estimated $10.3M increase.
  • John G. Ullman & Associates's biggest Q1 2021 reduction was Abbott, cutting an estimated $4.4M.
  • John G. Ullman & Associates fully exited Teradata in Q1 2021, selling an estimated $3.37M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $745M portfolio in Q1 2021.
  • John G. Ullman & Associates opened 13 new positions and closed 11 in Q1 2021.
  • John G. Ullman & Associates's portfolio value rose 16% quarter-over-quarter to $745M.

Based on John G. Ullman & Associates's 13F filing for Q1 2021, filed 22 Apr 2021.